CS
ASTH icon

Credit Suisse’s Astrana Health ASTH Stock Holding History

Credit Suisse’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$2.53M Buy
60,356
+3,442
+6% +$134K ﹤0.01% 1705
2023
Q4 		$2.18M Buy
56,914
+4,827
+9% +$161K ﹤0.01% 1822
2023
Q3 		$1.61M Sell
52,087
-2,260
-4% -$78K ﹤0.01% 1970
2023
Q2 		$1.72M Buy
54,347
+3,096
+6% +$106K ﹤0.01% 2021
2023
Q1 		$1.87M Buy
51,251
+2,558
+5% +$89.6K ﹤0.01% 1919
2022
Q4 		$1.44M Buy
48,693
+10,143
+26% +$326K ﹤0.01% 2088
2022
Q3 		$1.5M Buy
38,550
+1,686
+5% +$77.2K ﹤0.01% 2043
2022
Q2 		$1.42M Buy
36,864
+5,013
+16% +$191K ﹤0.01% 2139
2022
Q1 		$1.54M Buy
31,851
+3,241
+11% +$167K ﹤0.01% 2256
2021
Q4 		$2.1M Buy
28,610
+283
+1% +$23.3K ﹤0.01% 2749
2021
Q3 		$2.58M Buy
28,327
+2,463
+10% +$209K ﹤0.01% 2617
2021
Q2 		$1.62M Buy
25,864
+1,303
+5% +$48.2K ﹤0.01% 3022
2021
Q1 		$665K Sell
24,561
-9,724
-28% -$234K ﹤0.01% 3580
2020
Q4 		$626K Buy
34,285
+13,032
+61% +$234K ﹤0.01% 3672
2020
Q3 		$381K Sell
21,253
-929
-4% -$16K ﹤0.01% 3530
2020
Q2 		$366K Buy
22,182
+11,462
+107% +$180K ﹤0.01% 3481
2020
Q1 		$139K Sell
10,720
-2,229
-17% -$36.4K ﹤0.01% 3754
2019
Q4 		$239K Sell
12,949
-1,485
-10% -$24.6K ﹤0.01% 3923
2019
Q3 		$255K Buy
14,434
+2,485
+21% +$42.5K ﹤0.01% 3768
2019
Q2 		$199K Buy
+11,949
New +$217K ﹤0.01% 3843
2018
Q2 		– Sell
-26,086
Closed -$416K – 4173
2018
Q1 		$416K Buy
+26,086
New +$540K ﹤0.01% 3451

Other funds holding ASTH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Credit Suisse's ASTH Position: Q1 2024 in Review

Credit Suisse increased its Astrana Health (ASTH) stake by 6% in Q1 2024, buying an estimated $134K and bringing the position to 60,356 shares worth $2.53M. The position accounts for ﹤0.01% of the portfolio, ranked #1705.

Credit Suisse first reported a position in ASTH in Q1 2018 and has held it in 21 quarters since. The position peaked at $2.58M in Q3 2021. 159 funds tracked by Wall St. Rank hold ASTH as of Q1 2024.

  • Credit Suisse held 60,356 shares of Astrana Health worth $2.53M as of Q1 2024.
  • Credit Suisse bought 3,442 Astrana Health shares in Q1 2024, an estimated $134K.
  • Astrana Health made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #1705 holding.
  • Credit Suisse first reported a position in Astrana Health in Q1 2018 and has held it in 21 quarters since.
  • Credit Suisse's Astrana Health position peaked at $2.58M in Q3 2021.
  • 159 funds tracked by Wall St. Rank held Astrana Health as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.